Potential of heparin and nafamostat combination therapy for COVID-19.

Asakura, Hidesaku; Ogawa, Haruhiko

Asakura, Hidesaku; Ogawa, Haruhiko.

Asakura H; Department of Hematology, Kanazawa University Hospital, Kanazawa, Japan.
Ogawa H; Department of Environmental and Preventive Medicine, Kanazawa University, Kanazawa, Japan.

J Thromb Haemost ; 18(6): 1521-1522, 2020 06.

Article in English | MEDLINE | ID: covidwho-72070

Subject(s)

Coronavirus; Heparin; Anticoagulants; Benzamidines; Betacoronavirus; COVID-19; Coronavirus Infections; Guanidines; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Heparin / Coronavirus Limits: Humans Language: English Journal: J Thromb Haemost Journal subject: Hematology Year: 2020 Document Type: Article Affiliation country: Jth.14858

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google